OPELOR (PRODUIT PUR)

Numéro CAS : 56-75-7

Identification

Description


Formule moléculaire brute : C11H12Cl2N2O5

Principaux synonymes

Noms français :

  • 2,2-DICHLORO-N-(2-HYDROXY-1-(HYDROXYMETHYL)-2-(4-NITROPHENYL)ETHYL)ACETAMIDE
  • ACETAMIDE, 2,2-DICHLORO-N-(2-HYDROXY-1-(HYDROXYMETHYL)-2-(4-NITROPHENYL)ETHYL)-, (R-(R*,R*))-
  • ACETAMIDE, 2,2-DICHLORO-N-(BETA-HYDROXY-ALPHA-(HYDROXYMETHYL)-P-NITROPHENETHYL)-, D-THREO-(-)-
  • Chloramphénicol
  • D-(-)-THREO-2-DICHLOROACETAMIDO-1-P-NITROPHENYL-1,3-PROPANEDIOL
  • D-(-)-THREO-CHLORAMPHENICOL
  • D-THREO-(-)-2,2-DICHLORO-N-(BETA-HYDROXY-ALPHA-(HYDROXYMETHYL)-P-NITROPHENYL)ACETAMIDE
  • D-THREO-CHLORAMPHENICOL
  • D-THREO-N-(1,1'-DIHYDROXY-1-P-NITROPHENYLISOPROPYL)DICHLOROACETAMIDE
  • D-THREO-N-DICHLOROACETYL-1-P-NITROPHENYL-2-AMINO-1,3-PROPANEDIOL
  • N-(BETA-HYDROXY-ALPHA-(HYDROXYMETHYL)-P-NITROPHENETHYL) DICHLORO-2,2 ACETAMIDE
  • N-(HYDROXY-2, (HYDROXYMETHYL)-1 (P-NITROPHENYL)ETHYL)-2 DICHLORO-2,2 ACETAMIDE
  • P-NITROPHENYL-1 DICHLORO-1,1 ACETAMIDE-2 PROPANEDIOL-1,3

Noms anglais :

  • Chloramphenicol
Utilisation et sources d'émission

Médicament (antibiotique)

Références

Autres sources d'information

  • Lewis, R.J., Sax's dangerous properties of industrial materials. Vol. 1, 8ème éd. New York : Van Nostrand Reinhold. (1992).
  • Lenga, R.E. et Votoupal, K.L., The Sigma-Aldrich library of regulatory and safety data. Vol. 1. Milwaukee : Sigma-Aldrich. (1993). [RM-515040]
  • Grant, W.M., Toxicology of the eye : effects on the eyes and visual systems from chemicals, drugs, metals and minerals, plants, toxins and venoms; also, systemic side effects from eye medications. 3rd. ed. Springfield (ILL) : Charles C. Thomas. (1986).
  • Budavari, S. et O'Neil, M., The Merck index : an encyclopedia of chemicals, drugs, and biologicals. 11th ed. Rahway ( N.J.) : Merck. (1989). [RM-403001]
  • Schardein, J. L., Chemically induced birth defects. New York, N.Y. : M. Dekker. (1985).
  • Cronin, E., Contact dermatitis. New York : Churchill Livingstone. (1980). [RM-015008]
  • Contact Dermatitis, VOL. 14, 1986, P.176-178
  • Contact Dermatitis, VOL. 15, 1986, P.92
  • Contact Dermatitis, VOL. 21, 1989, P.121-122
  • Contact Dermatitis, VOL. 25, 1991, P.64-65
  • Contact Dermatitis, VOL. 26, 1992, P.66-67
  • Fisher, A.A., Fisher's contact dermatitis. 3ème. Philadelphia : Lea & Febiger. (1986).
  • Association pharmaceutique canadienne, CPS : compendium des produits et spécialités pharmaceutiques. 24e éd. Ottawa : L'Association. (1989). [RM-414001]
  • Wilson, J.T., Drugs in breast milk. Lancaster, England : MTP Press : International Medical Publishers. (1981). [MO-010024]
  • Briggs, G.G., Freeman, R.K. et Yaffe, S.J., Drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk. 2ème éd. Baltimore : Williams & Wilkins. (1986).
  • IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Pharmaceutical drugs. IARC monographs on the evaluation of carcinogenic risks, Vol. 50. Lyon : International Agency for Research on Cancer. (1990).   https://monographs.iarc.fr/wp-content/uploads/2018/06/mono50.pdf
    http://www.iarc.fr
  • Lewis, R.J., Reproductively active chemicals : a reference guide. New York : Van Nostrand Reinhold. (1991). [RM-515081]
  • Goodman, L. S. et Gilman, A., Goodman and Gilman's : the pharmacological basis of therapeutics. 7th ed. New York : Toronto : Macmillan Pub. Co. ; Collier Macmillan Canada. (1985).
  • Shepard, T.H., Catalog of teratogenic agents. 6th ed. London : John Hopkins University Press. (1989).

La cote entre [ ] provient de la banque Information SST du Centre de documentation de la CNESST.